The Priority Review

Clinical trials Brief

Emmes chosen as CRO partner for CARRA Registry & Biorepository

Emmes, part of Emmes Group, was selected to lead the next generation of the CARRA Registry & Biorepository under a Functional Service Provider model. The transition to the new hybrid operating model is expected to be completed in January 2028.

Primary source

Company press release (PR Newswire), November 17, 2026

Emmes Selected as CRO Partner for CARRA Registry & Biorepository, Supporting the Next Generation of Pediatric Rheumatology Research

Read the source: Emmes Selected as CRO Partner for CARRA Registry & Biorepository, Supporting the Next Generation of Pediatric Rheumatology Research prnewswire.com

Machine-summarized from the source above; not independently reported. How we use automation